Back to Results
First PageMeta Content
Micronucleus test / Biocompatibility / Hyaluronan / Toxicology / Medicine / ISO 10993 / Fecal incontinence


Microsoft PowerPoint - 1. CI_Core Intro_FINAL.ppt
Add to Reading List

Open Document

File Size: 535,99 KB

Share Result on Facebook

Company

Clinical Affairs Oceana Therapeutics Inc. / Safety Q-Med AB / Medical / Ames / /

Country

Columbia / Canada / /

Event

FDA Phase / /

Facility

Luke’s Roosevelt Hospital / Surgery Columbia U College of Physicians / University of Minnesota Solesta Study Design Clinical Efficacy Cindy Wong / /

IndustryTerm

study protocol / /

MedicalCondition

lymphoma assay Not / vesicoureteral reflux / fecal incontinence / /

Organization

FDA / MD VP / College of Physicians / Luke’s Roosevelt Hospital / Medical Devices Advisory Committee / University of Minnesota / /

Person

Howard Franklin / Anders Mellgren / Mitchell Bernstein / /

/

Position

Chief Medical Officer / Head / Fisher / Professor / Assistant / Professor of Surgery Unmet Need / Vice President / /

Product

Solesta / CI-10 / CI-8 / /

Technology

2004 2005 2006 2007 2008 2009 2010 Proof-of-concept Sweden Pivotal IDE study protocol / /

SocialTag